Nabors Industries Ltd.

NYSE: NBR
$29.87
-$1.84 (-5.8%)
Closing price July 10, 2020
One thing is for sure, the energy sector offers far more value than many others and makes sense to buy now as the price of oil heads towards the $70 a barrel level.
These five stocks trading under the $10 level could provide investors with some solid upside potential and could prove to be exciting additions to portfolios looking for solid alpha.
These five mid-cap stocks all have Buy ratings at Merrill Lynch, and they make sense for investors looking for growth that have a little risk tolerance.
The Merrill Lynch analysts remain positive on the U.S. land-based oilfield services companies, and three are top picks for investors now.
The best thing to do for 2018 and beyond is look for the sweet spots in the market where there is still some relative value. One of those areas for sure is energy, especially in oilfield services.
3 top oilfield services companies to buy that offer investors outstanding upside potential to Merrill Lynch price targets: HAL, NBR, PTEN.
Jefferies has five oilfield services top stocks for investors to consider, two solid picks for growth accounts and three very aggressive plays.
The top analyst upgrades, downgrades and other research calls from Wednesday include Equifax, Mallinckrodt, Nabors, Qualcomm, Salesforce and Snap.
The top analyst upgrades, downgrades and other research calls from Thursday include Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries and Wynn Resorts.
General Electric, AT&T, Nabors Industries, and Chesapeake Energy all posted new 52-week lows Wednesday.
The top analyst upgrades, downgrades and other research calls from Tuesday include Alphabet, Check Point Software, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger and Transocean.
The top analyst upgrades, downgrades and other research calls from Friday include Alibaba, Blue Apron, Gap, Harmony Gold, Myriad Genetics, Noble and Walmart.
J.C. Penney, Nabors Industries, Whiting Petroleum, and Synergy Pharmaceuticals all posted new 52-week lows Monday.
These four stocks have massive upside potential. While not suitable for all accounts, for those with higher risk tolerance these stocks could be huge winners for patient investors with a long horizon.
Clearly this a value play for investors, especially buying shares in front of what is expected to be declining or stagnant earnings. These companies have fought through oil price swings before, and...